Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
0(0%)
Results Posted
85%(11 trials)

Phase Distribution

Ph not_applicable
1
8%
Ph phase_1
2
15%
Ph phase_3
6
46%
Ph phase_2
3
23%

Phase Distribution

2

Early Stage

3

Mid Stage

6

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
2(16.7%)
Phase 2Efficacy & side effects
3(25.0%)
Phase 3Large-scale testing
6(50.0%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

13 of 13 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(13)

Detailed Status

Completed13

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (16.7%)
Phase 23 (25.0%)
Phase 36 (50.0%)
N/A1 (8.3%)

Trials by Status

completed13100%

Recent Activity

0 active trials
Showing 5 of 13
completednot_applicable

Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Treatment of Flank Fat

NCT07004010
completed

Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)

NCT03682471
completedphase_2

Phase 2 Study for the Treatment of Superficial Lipomas

NCT00608842
completedphase_3

Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01426373
completedphase_1

Deoxycholic Acid Injection for the Treatment of Superficial Lipomas

NCT00422188
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT07004010Not Applicable

Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Treatment of Flank Fat

Completed
NCT03682471

Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)

Completed
NCT00608842Phase 2

Phase 2 Study for the Treatment of Superficial Lipomas

Completed
NCT01426373Phase 3

Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area

Completed
NCT00422188Phase 1

Deoxycholic Acid Injection for the Treatment of Superficial Lipomas

Completed
NCT02007434Phase 3

Patient Experience Study of Deoxycholic Acid Injection

Completed
NCT00618722Phase 1

Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

Completed
NCT00618618Phase 2

Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

Completed
NCT01305577Phase 3

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Completed
NCT01032889Phase 2

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

Completed
NCT01546142Phase 3

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Completed
NCT01542034Phase 3

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Completed
NCT01294644Phase 3

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Completed

All 13 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
13